RA also has one of the highest economical burdens caused by an autoimmune disease.
RA is defined as a systemic autoimmune pathology associated with a chronic inflammatory process. It starts damaging joints and can affect heart, kidney, lung, digestive system, eye, skin and nervous system.
Newly diagnosed RA patients start with a therapy based in Methotrexate and only based on trial-and-error, they are then switched to other therapies . According to our first study, candidates show capabilities to anticipate patient clinical response after 6 months of Methotrexate treatment.
We have developed a new test that could evaluate the efficacy of Methotrexate (first line treatment) for individual patients diagnosed with Rheumatoid Arthritis.